The Net Margin of BioNexus Gene Lab Corp (BGLC) is -26.91%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2023-12-31 | -26.91% |
| 2022-12-31 | -3.29% |
| 2021-12-31 | 5.61% |
| 2020-12-31 | 9.57% |
| 2019-12-31 | -192.31% |
| 2018-12-31 | 14.29% |
| 2017-12-31 | -109.09% |